Comprehensive Genomic Profiling to Improve Access to Targeted Therapies in High-Grade Serous Carcinoma: A Real-World Study (PROMETHEUS)
Authors:
- Daniele LorenziniDLDaniele Lorenzini
- Francesca BarbettaFBFrancesca Barbetta
- Alberta PiccoloAPAlberta Piccolo
- Adele BusicoABAdele Busico
- Iolanda CaponeICIolanda Capone
- Elena ConcaECElena Conca
- Emma BragantiniEBEmma Bragantini
- Matteo DucaMDMatteo Duca
- Jacopo AzzolliniJAJacopo Azzollini
- Giovanna SabellaGSGiovanna Sabella
- Alice ArdoreAAAlice Ardore
- Nathalia Brito da CunhaNCNathalia Brito da Cunha
- 21 October 2026
- journal article
- Published by Elsevier in The Journal of Molecular Diagnostics
Abstract
No abstract availableFunding Information
- Ministero della Salute
This publication has 37 references indexed in Scilit:
- ESMO Clinical Practice Guideline Express Update on the management of epithelial ovarian cancerESMO Open, 2026
- ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practiceAnnals of Oncology, 2025
- Molecular tumor board for gynecologic malignancies: the real-world experience from the Department for Gynecology and Gynecologic Oncology of Kliniken Essen-MitteInternational Journal of Gynecological Cancer, 2024
- Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnosticsEuropean Journal of Cancer, 2024
- Real-world application of comprehensive genomic profiling for gynecological malignancies: a multicenter observational studyInternational Journal of Clinical Oncology, 2024
- Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working GroupAnnals of Oncology, 2024
- Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer—Development of Recommendations for Optimal Assay PerformanceLaboratory Investigation, 2024
- Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2023
- Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendationsAnnals of Oncology, 2022
- Targeting the DNA Damage Response in CancerMolecular Cell, 2015